<DOC>
	<DOC>NCT00270777</DOC>
	<brief_summary>A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, &amp; hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.</brief_summary>
	<brief_title>Improving Safety of Antivenom in People Bitten by Snakes</brief_title>
	<detailed_description />
	<mesh_term>Snake Bites</mesh_term>
	<mesh_term>Antivenins</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<criteria>Above 12 years of age Patients admitted to hospital after snake bite in whom antivenom is indicated Patients who give informed consent Patients who are pregnant or nursing Patients who are currently taking beta or alphaadrenoceptor antagonists, or tricyclic antidepressants Patients in whom adrenaline may be contraindicated (this may include patients with the following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and tachyarrhythmias)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Controlled trial</keyword>
	<keyword>Snake bite</keyword>
	<keyword>Safety</keyword>
	<keyword>Antivenom</keyword>
</DOC>